Key result
Cardiovascular imaging guides early detection and tailored management of ICI-induced cardiotoxicity.
Why the study?
Immune checkpoint inhibitors can cause rare but potentially life-threatening cardiotoxicity, necessitating synthesized evidence on early and tailored cardiovascular imaging strategies to optimize clinical management.
What is the role of multimodality cardiovascular imaging in the early detection and management of immune checkpoint inhibitor-induced cardiotoxicity?
What is the role of multimodality cardiovascular imaging in the early detection and management of immune checkpoint inhibitor-induced cardiotoxicity?
This review highlights the critical role of multimodality cardiovascular imaging in the early detection and management of potentially life-threatening cardiotoxicity associated with immune checkpoint inhibitors.
Answers are grounded in this paper and cite their sources.
Supports imaging surveillance in ICI recipients; leaves open need for prospective validation before practice change.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, significantly improving survival across various malignancies. However, these therapies are associated with various types of immune-related adverse events (irAEs), including cardiotoxicity, a spectrum of rare but potentially life-threatening complications impacting significantly morbidity and mortality. Cardiovascular imaging has become key in cardio-oncology, providing essential diagnostic tools for early detection and monitoring. This review synthesizes current evidence and underlines the pivotal role of early and tailored imaging strategies in managing ICI-induced cardiotoxicity. By bridging the knowledge gap, it aims to provide targetable insights to optimize the clinical management in patients undergoing immunotherapy.
No takes yet. Share an insight, caveat, or question.
Crosio et al. (2025) conducted a review in Immune checkpoint inhibitor-induced cardiotoxicity. Cardiovascular imaging was evaluated. Cardiovascular imaging plays a pivotal role in the early detection and tailored management of immune checkpoint inhibitor-induced cardiotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: